Table 2 Secondary outcome results
From: Effects of mind-body interventions on polycystic ovary syndrome: a comprehensive meta-analysis
Outcome categories | Outcome | No. of studies | MD (95%CI) | Heterogeneity (I2, %) |
|---|---|---|---|---|
Anthropometrics | Weight (kg) | 3 | 0.05 (-0.99, 1.09) | 3.1 |
BMI | 7 | -0.24 (-0.51, 0.03) | 0 | |
waist circumference (cm) | 2 | -0.46 (-1.44, 0.53) | 0 | |
hip circumference (cm) | 3 | -0.61 (-3.41, 2.19) | 43.01 | |
waist-hip ratio* | 4 | -0.02 (-0.03, -0.01) | 0 | |
Endocrine parameters | mFG score | 4 | -0.78 (-1.61, 0.06) | 68.40 |
FSH (mIU/mL) | 2 | -0.23 (-1.27,0.80) | 0 | |
LH | 2 | -2.68 (-11.56, 6.21) | 86.66 | |
LH/FSH ratio | 2 | -0.69 (-2.21, 0.83) | 66.68 | |
SHBG (nmol/L) | 2 | 8.87 (-4.99, 22.73) | 0 | |
DHEAS((µg/dL) | 2 | -16.98 (-51.52, 17.56) | 89.58 | |
Total testosterone(mmol/L) | 4 | -2.11 (-4.41, 0.18) | 91.75 | |
Free testosterone(pg/mL) | 2 | -0.94 (-2.30, 0.42) | 78.26 | |
glucose metabolism and blood lipid marker | Fasting insulin(µU/ml) | 3 | -2.88 (-6.31, 0.56) | 24.56 |
Fasting blood glucose (mmol/L) * | 3 | -0.25 (-0.36, -0.14) | 0 | |
HOMA-IR* | 4 | -0.69(-1.22, -0.15) | 0 | |
triglycerides(mmol/L) * | 4 | -0.21 (-0.41, -0.01) | 51.96 | |
HDL (mmol/L) | 4 | -0.02 (-0.09, 0.05) | 0 | |
LDL (mmol/L) | 4 | 0.04 (-0.27, 0.35) | 70.90 | |
Total cholesterol(mmol/L) | 3 | 0.05 (-0.27, 0.37) | 13.26 |